Resumes
Resumes
Eirik Nestaas Phones & Addresses
-
2130 42Nd Ave, San Francisco, CA 94116 (415) 665-6490
-
2340 15Th St, San Francisco, CA 94114
-
10 Darnby Ct, Orinda, CA 94563 (530) 587-3656
-
Shasta, CA
-
Richmond, CA
-
Novato, CA
-
Alameda, CA
Public records
Vehicle Records
Eirik Nestaas
View pageAddress:
10 Darnby Ct, Orinda, CA 94563
VIN:
JHLRE48777C118057
Make:
HONDA
Model:
CR-V
Year:
2007
Publications
Us Patents
Recombinant Human Interferon-Beta-1B Polypeptides
View pageUS Patent:
20050008616, Jan 13, 2005
Filed:
Jul 6, 2004
Appl. No.:
10/886414
Inventors:
Eirik Nestaas - San Francisco CA, US
Erno Pungor - Millbrae CA, US
Erno Pungor - Millbrae CA, US
Assignee:
Schering Aktiengesellschaft - Berlin
International Classification:
A61K038/21
US Classification:
424085600
Abstract:
The present invention relates to recombinant human interferon-β-1b (“IFN-β-1b”) polypeptides, or fragments, analogs, derivatives, or variants thereof, having an improved specific activity. The present invention also relates to pharmaceutical compositions comprising such IFN-β-1b polypeptides, or fragments, analogs, derivatives, or variants thereof, useful for treating multiple sclerosis. The present invention further relates to methods of producing such IFN-β-1b compositions.
Method And Apparatus For The Production Of Tgf-.Beta. And Purified Tgf-.Beta. Compositions
View pageUS Patent:
58640215, Jan 26, 1999
Filed:
Mar 16, 1992
Appl. No.:
7/838729
Inventors:
Erno Pungor - Foster City CA
Eirik Nestaas - Foster City CA
Eirik Nestaas - Foster City CA
Assignee:
Berlex Laboratories, Inc. - Wayne NJ
International Classification:
C07K 300
US Classification:
530416
Abstract:
Transforming growth factor. beta. (TGF-. beta. ) is produced in relatively large quantities and at a relatively high purity by fermentation in a perfusion microcarrier reactor. Conditioned media from the reactor is first treated to provide the active form of TGF-. beta. and subsequently purified by cation exchange chromatography followed by hydrophobic interaction chromatography. Optionally, nucleic acids complexed with the TGF-. beta. may be removed while the protein is bound to the cation exchange resin. Purified TGF-. beta. 1 compositions have a specific activity above 10. sup. 7 U/ml.
Method And Apparatus For The Production Of Tgf-.Beta.
View pageUS Patent:
50434314, Aug 27, 1991
Filed:
Sep 11, 1989
Appl. No.:
7/405695
Inventors:
Erno Pungor - Foster City CA
Eirik Nestaas - Foster City CA
Eirik Nestaas - Foster City CA
Assignee:
CODON - S. San Francisco CA
International Classification:
C07K 322
US Classification:
530399
Abstract:
Transforming growth factor. beta. (TGF-. beta. ) is produced in relatively large quantities and at a relatively high purity by fermentation in a perfusion microcarrier reactor. Conditioned media from the reactor is first treated to provide the active form of TGF-. beta. and subsequently purified by cation exchange chromatography followed by hydrophobic interaction chromatography. Optionally, nucleic acids complexed with the TGF-. beta. may be removed while the protein is bound to the cation exchange resin.